Liver enzymes in White Leghorns selected for the sheep red blood cell immune response

Poultry Science

Volumn 91, Issue 2, 2012, Pages 322-326

  Blevins, S ^a   Siegel, P B ^a   Blodgett, D J ^b   Ehrich, M ^b   Lewis, R M ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

Chicken; Enzyme activity; Liver

Indexed keywords

GALLUS GALLUS; OVIS ARIES;

EID: 84855948523     PISSN: 00325791     EISSN: 15253171     Source Type: Journal    
DOI: 10.3382/ps.2011-01764     Document Type: Article

References (24)

1. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
2. Burk, O., and L. Wojnowski. 2004. Cytochrome P450 3A and their regulation. Naunyn Schmiedebergs Arch. Pharmacol. 369:105-124.
3. Coulet, M., C. Eeckhoutte, and P. Galtier. 1996. Ontogenic development of drug-metabolizing enzymes in male chicken liver. Can. J. Physiol. Pharmacol. 74:32-37.
4. Crespi, C. L., V. P. Miller, and B. W. Penman. 1997. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal. Biochem. 248:188-190.
5. Fagerholm, R., B. Hofstetter, J. Tommiska, K. Aaltonen, R. Vrtel, K. Syrjakoski, A. Kallioniemi, O. Kilpivaara, A. Mannermaa, V. Kosma, M. Uusitupa, M. Eskelinen, V. Kataja, K. Aittomaki, K. von Smitten, P. Heikkila, J. Lukas, K. Holli, J. Bartkova, C. Blomqvist, J. Bartek, and H. Nevanlinna. 2008. NAD(P) H:quinone oxidoreductase 1 NQO1*2 genotype(P187S) is a strong prognostic and predictive factor in breast cancer. Nat. Genet. 40:844-853.
6. Gross, W. G., and P. B. Siegel. 1980. Production and persistence of antibodies in chickens to sheep erythrocyte. 2. Resistance to infectious diseases. Poult. Sci. 59:205-210.
7. Habig, W. H., M. J. Pabst, and W. B. Jakoby. 1974. Glutathione-S-transferases: The first step in mercapturic acid formation. J. Biol. Chem. 249:7130-7139.
8. Hart, S. N., Y. Cui, C. D. Klaassen, and X. Zhong. 2009. Three patterns of cytochrome P450 gene expression during liver maturation in mice. Drug Metab. Dispos. 37:116-121.
9. Hines, R. 2007. Ontogeny of human hepatic cytochrome P450. J. Biochem. Mol. Toxicol. 21:169-175.
10. Hines, R. N., and D. G. McCarver. 2002. The ontogeny of human drug-metabolizing enzymes: Phase I oxidative enzymes. J. Pharmacol. Exp. Ther. 300:355-360.
11. Ioannides, C. 2002. Pages 2-355 in Enzyme Systems that Metabolism Drugs and Other Xenobiotices. John Wiley & Sons, West Sussex, UK.
12. Jang, I., K. Chae, and J. Cho. 2001. Effects of age and strain on small intestinal and hepatic antioxidant defense enzymes in Wistar and Fisher 344 rats. Mech. Ageing Dev. 122:561-570.
13. Jung, K., and W. Henke. 1996. Developmental changes of antioxidant enzymes in kidney and liver from rats. Free Radic. Biol. Med. 20:613-617.
14. Kaplowitz, N., J. Kuhlenkamp, and G. Clifton. 1975. Drug induction of hepatic glutathione-S-transferases in male and female rats. Biochem. J. 146:351-356.
15. Kuehn, L. A., S. E. Price, C. F. Honaker, and P. B. Siegel. 2006. Antibody responses of chickens to sheep red blood cells: Crosses among divergently selected lines and sublines. Poult. Sci. 85:1338-1341.
16. Lorr, N. A., and S. E. Bloom. 1987. Ontogeny of the chicken cytochrome P-450 enzyme system. Biochem. Pharmacol. 36:3059-3067.
17. Mannervik, B., and P. Jemth. 1999. Measurement of glutathione transferases. Pages 6.4.1-6.4.9 in Current Protocols in Toxicology. M. D. Maines, G. Costa, D. J. Reed, S. Sassa, and I. G. Sipes, ed. John Wiley & Sons, Hoboken, NJ.
18. Martin, A., and E. A. Dunnington. 1990. Production traits and alloantigen systems in lines of chickens selected for high or low antibody responses to sheep erythrocytes. Poult. Sci. 69:871-878.
19. Maurice, D. V., S. F. Lightsey, H. Kuo-Tung, and J. F. Rhoades. 1991. Comparison of glutathione-S-transferase activity in the rat and birds: Tissue distribution and rhythmicity in chick (Gallus domesticus) liver. Comp. Biochem. Physiol. 100B:471-474.
20. Nebert, D. W., A. L. Roe, S. E. Vandale, E. Bingham, and G. G. Oakely. 2002. NAD(P)H:quinone oxidoreductase (NQ01) polymorphism, exposure to benzene, and predisposition to disease: A HuGE review. Genet. Med. 4:62-70.
21. Prochaska, H. J., and A. B. Santamaria. 1988. Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: A screening assay for anticarcinogenic enzyme inducers. Anal. Biochem. 169:328-336.
22. Talalay, P., and A. T. Dinkova-Kostova. 2004. Role of nicotinamide quinone oxidoreductase 1 (NQ01) in protection against toxicity of electrophiles and reactive oxygen intermediates. Methods Enzymol. 382:355-364.
23. Wauthier, V., R. K. Verbeeck, and P. Buc Calderon. 2007. The effect of ageing on cytochrome P450 enzymes: Consequences for drug metabolizing biotransformation in the elderly. Curr. Med. Chem. 14:745-757.
24. Waxman, D. J., and M. G. Holloway. 2009. Centennial perspectives: Sex differences in the expression of hepatic drug metabolizing enzymes. Mol. Pharmacol. doi:10.1124/mol.109.056705.